Publications by authors named "Yosuke Nonaka"

Claim this Profile
P
Pseudogap in electron-doped cuprates: Strong correlation leading to band splitting.
Masafumi Horio, Shiro Sakai, Hakuto Suzuki, Yosuke Nonaka, Makoto Hashimoto

Proc Natl Acad Sci U S A· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achondroplasia: aligning mouse model with human clinical studies shows crucial importance of immediate postnatal start of the therapy.
Gustavo Rico-Llanos, Frantisek Spoutil, Eva Blahova, Adolf Koudelka, Michaela Prochazkova, Yosuke Nonaka

J Bone Miner Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice.
Takeshi Kimura, Michaela Bosakova, Yosuke Nonaka, Eva Hruba, Kie Yasuda

Sci Transl Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease.
Yusaku Matsuda, Yosuke Nonaka, Satoshi Futakawa, Hirotaka Imai, Kazumasa Akita

Mol Ther Nucleic Acids· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Chymase Inhibitory RNA Aptamer Improves Cardiac Function and Survival after Myocardial Infarction.
Denan Jin, Shinji Takai, Yosuke Nonaka, Satoko Yamazaki, Masatoshi Fujiwara

Mol Ther Nucleic Acids· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FGF2 aptamer inhibits the growth of FGF2-FGFR pathway driven lung cancer cells.
Junko Hamamoto, Hiroyuki Yasuda, Yosuke Nonaka, Masatoshi Fujiwara, Yoshikazu Nakamura

Biochem Biophys Res Commun· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain.
Ling Jin, Yosuke Nonaka, Shin Miyakawa, Masatoshi Fujiwara, Yoshikazu Nakamura

Mol Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for specific inhibition of Autotaxin by a DNA aptamer.
Kazuki Kato, Hisako Ikeda, Shin Miyakawa, Satoshi Futakawa, Yosuke Nonaka

Nat Struct Mol Biol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective inhibition of the kinase DYRK1A by targeting its folding process.
Isao Kii, Yuto Sumida, Toshiyasu Goto, Rie Sonamoto, Yukiko Okuno, Yosuke Nonaka

Nat Commun· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.
Yasushi Ogawa, Yosuke Nonaka, Toshiyasu Goto, Eriko Ohnishi, Toshiyuki Hiramatsu

Nat Commun· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods.
Yosuke Nonaka, Takeshi Hiramoto, Norihisa Fujita

Biochem Biophys Res Commun· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of endogenous surrogate ligands for human P2Y receptors through an in silico search.
Takeshi Hiramoto, Yosuke Nonaka, Kazuko Inoue, Takefumi Yamamoto, Mariko Omatsu-Kanbe

J Pharmacol Sci· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis